You are here

Article info

Article menu
Download PDFPDF
Clinical science
Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times

Authors

  1. Correspondence to Dr Philipp S Muether, Department of Ophthalmology, University of Cologne, Kerpener Strasse 62, Cologne 50924, Germany; philmuether{at}mac.com
View Full Text

Citation

Fauser S, Muether PS
Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times
British Journal of Ophthalmology 2016;100:1494-1498.

Publication history

  • Received December 15, 2015
  • Revised January 19, 2016
  • Accepted January 23, 2016
  • First published February 17, 2016.
Online issue publication 
November 28, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/